Response Evaluation of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas: The Usefulness of Sonazoid-Enhanced Harmonic Sonography
Yu Xia(Chinese Academy of Agricultural Sciences), Kiyoshi Maekawa(Kindai University), Chie Tatsumi(Kindai University), Satoru Hagiwara(Kindai University Hospital), Hobyung Chung(Kindai University), Masatoshi Kudo(Kindai University), Satoshi Kitai(Kindai University), Shunsuke Takahashi(Kanagawa Dental University), Yasunori Minami, Kazuomi Ueshima(Kindai University), Kinuyo Hatanaka(Union Hospital), Tatsuo Inoue, Emi Ishikawa(Kyowa Chemical Industry (Japan)), Taisuke Ueda(Kindai University), Sosuke Hayaishi(Union Hospital)
Cited by 67
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing
|PLoS ONE|2014|1.5k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k